Updates

May 22, 2019
Treatment Intensity Should Be Personalized in Women with HER2-positive Breast Cancer, Study Says

Personalized treatment intensity is crucial to the success of less toxic and demanding therapies for women with HER2-positive breast cancer, according to a spokesperson ... Read more
May 20, 2019
Young Women More Likely to Face Aggressive BC Types, But Proper Treatment Improves Outcomes

Young women are more likely than older ones to be diagnosed with more aggressive forms of breast cancer, but their outcomes can be good ... Read more
May 15, 2019
Experimental Antibody Therapy Leads to Significant Responses in HER2-positive Breast Cancer, Phase 2 Trial Shows

Trastuzumab deruxtecan (DS-8201), an investigational antibody-drug conjugate developed by AstraZeneca with Daiicho Sankyo, led to clinically meaningful responses in patients with advanced HER2-positive breast ... Read more
May 14, 2019May 9, 2019
Here I Am

I remember when my daughter performed at a talent show at her school. I’d just had my fourth round of chemotherapy, and my ... Read more
May 13, 2019
Radiation Therapy Reduces Chances of Breast Cancer Returning in Women with Early, Hormone-Positive Disease, Trial Shows

Women with early, low-risk hormone receptor-positive breast cancer are significantly less likely to see their disease return if given radiation therapy and ... Read more

News

Kadcyla Approved in US for Some HER2-positive Early Breast Cancer Patients
May 10, 2019
The U.S. Food and Drug Administration (FDA) has extended the use of Genentech‘s Kadcyla (ado-trastuzumab emtansine) ...
News

SHARE Introduces My MBC & Me App for Metastatic Breast Cancer Patients
May 6, 2019
Since her diagnosis of metastatic breast cancer two years ago, Karen Peterson has been ...
News

New Imaging Tool Captures Process That Turns Tumor Cells Malignant in Breast Cancer
May 3, 2019
A new imaging technique that visualizes individual cells with high resolution may improve the ...
A Lump in the Road - A Column by Nancy Brier, Columns

Walking on Broken Glass
April 30, 2019April 26, 2019
My family and I stopped to look at art this week. While we wandered ...
News

Clinical Trial Will Test Investigational Therapy Targeting ‘Dormant’ Breast Cancer Cells
April 29, 2019April 29, 2019
GlycoMimetics is planning a clinical trial testing its therapy candidate GMI-1359 as a treatment ...
News

Surgery That Removes All Traces of Breast Cancer Stimulates Protective Anticancer Immune Response, Mouse Study Suggests
April 26, 2019
Breast cancer surgery with negative or clear margins, which leaves no signs of cancer behind, ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Liposomal Irinotecan Shows Promising Phase 1 Results in Heavily Treated Breast Cancer Patients
April 24, 2019
Treatment with a liposomal formulation of irinotecan — meaning the chemotherapy is wrapped up ...
Antibiotic in Long Use for Leprosy, Clofazimine, May Treat Triple-negative Breast Cancer, Mouse Study Suggests
April 22, 2019
Clofazimine, an antibiotic long used for treating leprosy and tuberculosis, may be repurposed as a ...
AstraZeneca Teams with Daiichi Sankyo to Speed Development of HER2-positive Advanced Breast Cancer Therapy
April 17, 2019
It’s Probably Nothing
April 16, 2019April 15, 2019
Lynparza Approved in EU to Treat Subset of Advanced Breast Cancer
April 15, 2019
Surgery Extends Lives of Women with Metastatic Breast Cancer, Study Says
April 12, 2019

FDA Approves Ibrance Combo Therapy for Some Male Breast Cancers
April 10, 2019
The U.S. Food and Drug Administration (FDA) has expanded the use of Ibrance (palbociclib) capsules ...
Time-Restricted Feeding May Cut Tumor Risk in Obese Women, Mouse Study Suggests
April 8, 2019
Faslodex-Arimidex Improves Survival in Post-menopausal Women with Advanced BC, Trial Shows
April 5, 2019
FDA Proposes New Policies to Modernize, Improve Quality of Mammography Screenings
April 3, 2019

Doc, You’re a Downer. Let Me Revel in My 5-Year Mark
April 2, 2019March 29, 2019
I met a guy at a party. At first, he was quite the charmer, ...
Breast Cancer Survivors Weigh in on Ways to Reduce the Financial Burden of the Disease
April 1, 2019
Frying Oil Reheated Often, Like in Deep Frying, Seen to Promote Breast Cancer’s Spread in Animal Study
March 29, 2019

News

Molecular Patterns of Breast Cancer May Predict Chance of Relapse Up to 20 Years Later
March 27, 2019
Screening a woman’s breast cancer for certain genetic and molecular patterns may be used ...
News

Estrogen May Trigger Brain Metastasis in Triple-negative Breast Cancer, Study Shows
March 25, 2019
Estradiol, a type of estrogen and the major female hormone, may drive the spread ...
News

AI Matches Radiologists’ Skill at Detecting Breast Cancer on Mammograms
March 22, 2019
An artificial intelligence (AI) system based on deep learning algorithms is able to detect ...
News

CHMP Favors EU Approval of Lynparza for Some Advanced Breast Cancers
March 20, 2019
The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines ...
A Lump in the Road - A Column by Nancy Brier, Columns

Reaching the Double Nickel
March 19, 2019March 18, 2019
I shivered in the parking lot at my kid’s school with four other moms. ...
News

Vitamin C Might Reverse Stress-induced Driver of Breast Cancer, Study Says
March 18, 2019
Chronic stress and the consequent release of the stress hormone epinephrine may help breast ...
News

FDA Grants Accelerated Approval to Tecentriq-Abraxane Combo for Some TNBC
March 15, 2019
The U.S. Food and Drug Administration has granted accelerated approval to a combination of ...
News

Thousands of Lives Spared Thanks to Screening, Treatment, Study Reports
March 13, 2019
Since 1989, between 384,000 and 615,000 women’s lives have been spared thanks to significant ...
News

NeuVax/Herceptin Combo Promotes Disease-free Survival in TNBC
March 11, 2019
Long-term treatment with a combination of NeuVax (nelipepimut-S) and Herceptin (trastuzumab) is safe and extends the ...
News

FDA Approves Under-the-skin Formulation of Herceptin for Certain Breast Cancers
March 8, 2019
The U.S. Food and Drug Administration (FDA) has approved an under-the-skin formulation of Genentech‘s breast ...
News

Imaging Agent May Provide Early Info About Benefits of Hormone Therapies for Breast Cancer
March 6, 2019
A new imaging agent that successfully measures changes in progesterone receptor (PR) levels may ...
A Lump in the Road - A Column by Nancy Brier, Columns

How to Tell Your Kid You Have Cancer: 7 Tips
March 5, 2019March 4, 2019
The hardest part of cancer? That’s a loaded question, but telling my kid ...
News

Cellular Barcoding Sheds Light on Spread, Drug Resistance of TNBC
March 4, 2019
Very few cancer cells within a triple negative breast tumor (TNBC) are able to ...
News

Pfizer’s Biosimilar Zirabev Approved in E.U. for Advanced Breast, Other Cancers
March 1, 2019
Metastatic breast cancer patients in the European Union will have the possibility of being ...
News

Sacituzumab Govitecan Shinks Tumors in One of Three Metastatic TNBC Patients, Trial Shows
February 27, 2019
One in three women with metastatic triple-negative breast cancer — all of whom had received ...
A Lump in the Road - A Column by Nancy Brier, Columns

Fingers on My Breasts and Questions on My Mind
February 26, 2019February 22, 2019
While my doctor’s fingers massaged my breasts and cradled my hard, almond-sized lump, we ...
News

More Intense Chemotherapy May Lower Risk of Breast Cancer Recurrence and Death, Study Says
February 25, 2019
Reducing the interval between chemotherapy treatment cycles or administering chemotherapy medications sequentially at higher ...
News

Plerixafor Improves Immunotherapy Response in Mouse Model of Breast Cancer
February 22, 2019
Plerixafor — approved for the treatment of lymphoma and multiple myeloma — decreases tumor fibrosis ...

June 22, 2018June 22, 2018

Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU

News

The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more

Pin It on Pinterest